Home › Rating Schedule

Skin: VA Rating Schedule

The schedule for this body system is at 38 CFR §4.118 and covers 30 diagnostic codes. Select a code to see the official criteria for each percentage level.

CodeConditionLevels in the schedule
7800Burn scar(s) of the head, face, or neck; scar(s) of the head, face, or neck due to other causes; or other disfigurement of the head, face, or neck80%, 50%, 30%, 10%
7801Burn scar(s) or scar(s) due to other causes, not of the head, face, or neck, that are associated with underlying soft tissue damage40%, 30%, 20%, 10%
7802Burn scar(s) or scar(s) due to other causes, not of the head, face, or neck, that are not associated with underlying soft tissue damage10%
7804Scar(s), unstable or painful30%, 20%, 10%
7805Scars, other; and other effects of scars evaluated under diagnostic codes 7800, 7801, 7802, or 780460%, 30%, 10%, 0%
7806Dermatitis or eczema60%, 30%, 10%, 0%
7807American (New World) leishmaniasis (mucocutaneous, espundia)See entry
7808Old World leishmaniasis (cutaneous, Oriental sore)See entry
7809Discoid lupus erythematosus60%, 30%, 10%, 0%
7811Tuberculosis luposa (lupus vulgaris), active or inactiveSee entry
7813Dermatophytosis (ringworm60%, 30%, 10%, 0%
7815Bullous disorders (including pemphigus vulgaris, pemphigus foliaceous, bullous pemphigoid, dermatitis herpetiformis, epidermolysis bullosa acquisita, benign chronic familial pemphigus (Hailey-Hailey), and porphyria cutanea tarda)60%, 30%, 10%, 0%
7816Psoriasis60%, 30%, 10%, 0%
7817Erythroderma100%, 60%, 30%, 10%, 0%
7818Malignant skin neoplasms (other than malignant melanoma)See entry
7819Benign skin neoplasmsSee entry
7820Infections of the skin not listed elsewhere (including bacterial, fungal, viral, treponemal, and parasitic diseases)60%, 30%, 10%, 0%
7821Cutaneous manifestations of collagen-vascular diseases not listed elsewhere (including scleroderma, calcinosis cutis, subacute cutaneous lupus erythematosus, and dermatomyositis)60%, 30%, 10%, 0%
7822Papulosquamous disorders not listed elsewhere (including lichen planus, large or small plaque parapsoriasis, pityriasis lichenoides et varioliformis acuta (PLEVA), lymphomatoid papulosus, mycosis fungoides, and pityriasis rubra pilaris (PRP))60%, 30%, 10%, 0%
7823Vitiligo10%, 0%
7824Diseases of keratinization (including icthyoses, Darier's disease, and palmoplantar keratoderma)60%, 30%, 10%, 0%
7825Chronic urticaria60%, 30%, 10%
7826Vasculitis, primary cutaneous60%, 30%, 10%
7827Erythema multiforme; Toxic epidermal necrolysis60%, 30%, 10%
7828Acne30%, 10%, 0%
7829Chloracne30%, 20%, 10%, 0%
7830Scarring alopecia20%, 10%, 0%
7831Alopecia areata10%, 0%
7832Hyperhidrosis30%, 0%
7833Malignant melanomaSee entry

General Rating Formula For The Skin

Evaluation criteriaRating
At least one of the following60%
Characteristic lesions involving more than 40 percent of the entire body or more than 40 percent of exposed areas affected; or
Constant or near-constant systemic therapy including, but not limited to, corticosteroids, phototherapy, retinoids, biologics, photochemotherapy, psoralen with long-wave ultraviolet-A light (PUVA), or other immunosuppressive drugs required over the past 12-month period60%
At least one of the following30%
Characteristic lesions involving 20 to 40 percent of the entire body or 20 to 40 percent of exposed areas affected; or Systemic therapy including, but not limited to, corticosteroids, phototherapy, retinoids, biologics, photochemotherapy, PUVA, or other immunosuppressive drugs required for a total duration of 6 weeks or more, but not constantly, over the past 12-month period
At least one of the following10%
Characteristic lesions involving at least 5 percent, but less than 20 percent, of the entire body affected; or
At least 5 percent, but less than 20 percent, of exposed areas affected; or
Intermittent systemic therapy including, but not limited to, corticosteroids, phototherapy, retinoids, biologics, photochemotherapy, PUVA, or other immunosuppressive drugs required for a total duration of less than 6 weeks over the past 12-month period
No more than topical therapy required over the past 12-month period and at least one of the following0%
Characteristic lesions involving less than 5 percent of the entire body affected; or
Characteristic lesions involving less than 5 percent of exposed areas affected
Or rate as disfigurement of the head, face, or neck (DC 7800) or scars (DCs 7801, 7802, 7804, or 7805), depending upon the predominant disability. This rating instruction does not apply to DC 7824

Source: eCFR Title 38, §4.118, current as of 2026-11-05. Criteria are reproduced verbatim for reference.